TRANSDERMAL NON-AQUEOUS NANOEMULGELS FOR SYSTEMIC DELIVERY OF AROMATASE INHIBITOR
Transdermal nanoemugels for systemic delivery of potent drugs like aromatase inhibitors letrozole and anastrozole are disclosed. The disclosed compositions may include gelling agent, surfactants, cosolvents, and oily components. The process of preparing the nanoemulgels is simple and the formation of nanoemulgels is spontaneous. Penetration enhancers are included in the compositions of the transdermal nanoemugels. The compositions have penetration power with emollient effects to the skin. The transdermal drug delivery system may be applied to skin in a single dose that produces pharmacologically effective blood concentration of the potent drug for one week or up to one month depending on the amount and thickness of the applied nanoemugels in the transdermal matrix patches.The nanoemulgels can be used for topical delivery of NSAID..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Europäisches Patentamt - (2020) vom: 28. Okt. Zur Gesamtaufnahme - year:2020 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
SALLAM ASSAYED ALARABI NAUMAN [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Sonstige Themen: |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2020-10-28, Last update posted on www.tib.eu: 2023-12-19, Last updated: 2023-12-22 |
---|
Patentnummer: |
EP3727363 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA006174434 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA006174434 | ||
003 | DE-627 | ||
005 | 20231222110532.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210531s2020 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA006174434 | ||
035 | |a (EPA)EP3727363 | ||
035 | |a (EPA)66994508 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a SALLAM ASSAYED ALARABI NAUMAN |e verfasserin |4 aut | |
245 | 1 | 0 | |a TRANSDERMAL NON-AQUEOUS NANOEMULGELS FOR SYSTEMIC DELIVERY OF AROMATASE INHIBITOR |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2020-10-28, Last update posted on www.tib.eu: 2023-12-19, Last updated: 2023-12-22 | ||
520 | |a Transdermal nanoemugels for systemic delivery of potent drugs like aromatase inhibitors letrozole and anastrozole are disclosed. The disclosed compositions may include gelling agent, surfactants, cosolvents, and oily components. The process of preparing the nanoemulgels is simple and the formation of nanoemulgels is spontaneous. Penetration enhancers are included in the compositions of the transdermal nanoemugels. The compositions have penetration power with emollient effects to the skin. The transdermal drug delivery system may be applied to skin in a single dose that produces pharmacologically effective blood concentration of the potent drug for one week or up to one month depending on the amount and thickness of the applied nanoemugels in the transdermal matrix patches.The nanoemulgels can be used for topical delivery of NSAID. | ||
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a che | |
650 | 4 | |a 615 | |
700 | 0 | |a YOUNES HUSAM M |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2020) vom: 28. Okt. |
773 | 1 | 8 | |g year:2020 |g day:28 |g month:10 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/66994508/publication/EP3727363A1?q=EP3727363 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
936 | u | w | |j 2020 |b 28 |c 10 |
951 | |a AR | ||
952 | |j 2020 |b 28 |c 10 |